Currently set to Index
Currently set to Follow

Category: COVID-19

Free access SCORAD original papers

The two founding papers of the SCORAD index are now in free access. Thanks to Prof. Jean-François STALDER who led the negotiations with Karger.  Severity Scoring of Atopic Dermatitis: The SCORAD Index ➜ Consensus Report of the European Task Force on Atopic Dermatology1993;186:23–31. Nantes & Bordeaux, FR Web of Science Citations: 1416 / In the […]

Read More

COVID-19 statements from the ETFAD

Two statements from the European Task Force on Atopic Dermatitis (ETFAD) on Corona virus (Covid-19) and Atopic Dermatitis Risk of severe allergic reactions to COVID-19 vaccines among patients with allergic skin diseases – practical recommendations. A position statement of ETFAD with external experts ➜ J Eur Acad Dermatol Venereol, 2021 Mar 22. doi: 10.1111/jdv.17237. Online […]

Read More

SECURE-AD registry and Patient survey update

SECURE-AD is a global registry of patients with atopic dermatitis who experience a COVID-19 episode:➜ SECURE-AD registry We encourage clinicians worldwide to report all cases of COVID-19 in their atopic eczema patients, treated with or without systemic immunomodulating medication, regardless of severity (including asymptomatic patients detected through public health screening). There are currently 238 cases reported in the SECURE-AD […]

Read More

ISAD 2020 (live) – Focus on Introductory lecture

Dear Colleagues, Dear Friends, We are now less than 3 weeks from our live digital AD meeting. After this long period where international interactions have been suddenly severed, we resume during this short event the experience of live global meetings with novel digital instruments, which a priority given to scientific discussion. If you have not […]

Read More

COVID-19 registry

COVID-19 registry for atopic dermatitis patients (SECURE-AD) Have any of your patients with atopic dermatitis developed COVID-19? Please report your cases to SECURE-AD via a simple anonymised case report form.  SECURE-AD is a global registry for healthcare professionals to report outcomes of COVID-19 in individuals with atopic dermatitis.  Entering your cases is quick and can […]

Read More

COVID-19 statement from the ETFAD

Statement from the European Task Force on Atopic Dermatitis (ETFAD) on Corona virus (Covid-19) and Atopic Dermatitis On March 11th the Director-General of the World Health Organization declared the Covid-19 to be a pandemic with wide implications for the population around the world. The total number of cases around the world is increasing exponentially and […]

Read More
ISAD2021 banner

ISAD 2020 postponing notice

Dear Colleagues, Dear Friends, Because of the COVID-19 pandemic and its consequences for international travel, the ISAD executive committee and ISAD 2020 Local Organizing Committee (LOC) have jointly decided to postpone the ISAD meeting to April 19-21 2021 at the same venue in Seoul. Information on the pre-meetings will follow in due course. Because of […]

Read More